Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...

More Viking Age silver has been discovered per square kilometer on the Isle of Man than in England, Ireland, Scotland, and ...

TPG's Ashley Kosciolek accepted a free trip from Viking Cruises to sail on Viking Mississippi. The opinions expressed below ...

Fintel reports that on November 12, 2024, Morgan Stanley upgraded their outlook for Viking Holdings (NYSE:VIK) from ...

Viking Therapeutics (VKTX) surges on promising obesity drug results. Explore key price levels and analyst insights in this detailed analysis.

Viking Therapeutics stock is volatile Monday after the pharma company released positive data for its weight-loss drug. Here's ...

Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...

Ship-shaped graves have been identified at the site, which came to light during investigations of an earlier Stone Age ...

Sam Darnold has experienced a career revival his his first season with the Minnesota Vikings.

What if, however, you didn’t have to fuss with finicky hacks or wash extra loads of laundry at all? Thanks to luxury kitchen ...

The biotech had tested the oral asset, dubbed VK2735, at doses ranging from 2.5 mg up to 100 mg. Viking already revealed back in March that 25% of the eight patients who received 20-mg doses saw their ...

On Tuesday, Viking Therapeutics Inc (VKTX) stock saw a decline, ending the day at $60.6 which represents a decrease of $-2.37 or -3.76% from the prior close of $62.97. The stock opened at $62.46 and ...